Notice: This CMS-approved document has been submitted - Philips ...

CMS-1403-FC
period of 12 months and reporting that identifies whether
A1c control is good (that is, A1c ≤ 7.0 percent), moderate
(that is, A1c ≤ 9.0 percent, but > 7.0 percent), or poor
(that is, A1c > 9.0 percent). Another commenter requested
that CMS re-evaluate the use of inpatient site of service
codes (99241 through 99245) for Measure #5 Heart Failure:
Angiotensin-Converting Enzyme (ACE) Inhibitor or
Angiotensin Receptor Blocker (ARB) Therapy for Left
Ventricular Systolic Dysfunction (LVSD), Measure #6 CAD:
Oral Antiplatelet Therapy Prescribed for Patients with CAD,
Measure #7 CAD: Beta-Blocker Therapy for CAD Patients with
Prior MI, and Measure #8 Heart Failure: Beta-Blocker
Therapy for LVSD. Also another commenter requested the
addition of specifications for inpatient reporting for
Measure #56 Community-Acquired Pneumonia (CAP): Vital
Signs, Measure #57 CAP: Assessment of Oxygen Saturation,
Measure #58 CAP: Assessment of Mental Status, and Measure
#59 CAP: Empiric Antibiotic. One commenter expressed
gratitude that audiologists are now eligible to participate
in PQRI and willingness to work with the measure developer
to expand Measure #94 Otitis Media with Effusion (OME):
Diagnostic Evaluation – Assessment of Tympanic Membrane
Mobility and Measure #95 Otitis Media with Effusion (OME):
Hearing Testing. Lastly, one commenter requested that we
612